{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:03:14Z","timestamp":1792015394959,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Roche Diagnostics"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejogrb.2019.02.022","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T10:46:25Z","timestamp":1551523585000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Evaluation of the Elecsys\u00ae anti-M\u00fcllerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol"],"prefix":"10.1016","volume":"236","author":[{"given":"Ellen","family":"Anckaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Denk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L.","family":"Torrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Broekmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2019.02.022_bib0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750.pub3","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","article-title":"Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis","volume":"100","author":"Broer","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/humupd\/dmq015","article-title":"Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis","volume":"16","author":"van Loendersloot","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/GCO.0000000000000175","article-title":"Ovarian response biomarkers: physiology and performance","volume":"27","author":"Iliodromiti","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1472-6874-12-29","article-title":"The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial","volume":"12","author":"van Tilborg","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0040","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of\u2019 poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/humrep\/deu266","article-title":"Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Mullerian hormone","volume":"30","author":"Hamdine","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0092-8674(86)90783-X","article-title":"Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0055","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/rep.1.01178","article-title":"Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary","volume":"132","author":"Modi","year":"2006","journal-title":"Reproduction"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0065","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2014.12.114","article-title":"Comparison of antimullerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0070","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","article-title":"Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0075","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0080","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0085","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0090","series-title":"Nederlandse Vereniging voor Obstetrie & Gynaecologie. Ovarieel hyperstimulatiesyndroom","year":"2008"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0100","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/297397","article-title":"Early prediction of preeclampsia","volume":"2014","author":"Poon","year":"2014","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0105","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.fertnstert.2015.01.004","article-title":"Prospective study into the value of the automated Elecsys antimullerian hormone assay for the assessment of the ovarian growing follicle pool","volume":"103","author":"Anderson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clinbiochem.2015.10.008","article-title":"Multicenter analytical performance evaluation of a fully automated anti-Mullerian hormone assay and reference interval determination","volume":"49","author":"Anckaert","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0115","first-page":"1","article-title":"Objective multicentre performance of the automated assays for AMH and estimation of established critical concentrations","volume":"8","author":"Fleming","year":"2017","journal-title":"Hum Fertil (Camb)"},{"issue":"Supplement (4)","key":"10.1016\/j.ejogrb.2019.02.022_bib0120","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/j.fertnstert.2018.07.926","article-title":"Prediction of ovarian response with an automated AMH assay (Elecsys) in GnRH antagonist cycles","volume":"110","author":"Bosch","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0125","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/humrep\/dex219","article-title":"Non-equivalence of anti-M\u00fcllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing","volume":"32","author":"Iliodromiti","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0130","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1093\/humrep\/des260","article-title":"Anti-M\u00fcllerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability","volume":"27","author":"Rustamov","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.rbmo.2013.07.008","article-title":"Anti-Mullerian hormone versus antral follicle count for defining the starting dose of FSH","volume":"27","author":"Lan","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2019.02.022_bib0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519300909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211519300909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:45:20Z","timestamp":1759556720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211519300909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":29,"alternative-id":["S0301211519300909"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.02.022","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Elecsys\u00ae anti-M\u00fcllerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2019.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Roche Diagnostics International Ltd (Rotkreuz). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}